Lijun Liu

10PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersMolecular targetsCardiology (incl. cardiovascular diseases)Epigenetics (incl. genome methylation and epigenomics)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 31, 2026
Glucocorticoid-Modulated Molecular Signatures and Prediction of Treatment Efficacy in IgA Nephropathy.

|Apr 08, 2026
Endothelin Receptor Antagonist Ambrisentan, Sodium-Glucose Cotransporter 2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy: A Randomized Crossover Trial.

Qinlan Chen, Pei Chen, Lijun Liu

|Jan 21, 2026
CFHR3*B Haplotype, Complement Activation, and Risk of IgA Nephropathy.

Yongji Zhang, Honghong Zou, Xinran Ni

|Jan 21, 2026
Genetic Determinants of Steroid Responsiveness in IgA Nephropathy.

Lin-Lin Xu, Xu-Jie Zhou, Wenjian Bi

|Aug 31, 2023
Mesangial C3 Deposition, Complement-Associated Variant, and Disease Progression in IgA Nephropathy.

Yuqi Kang, Boyang Xu, Sufang Shi

|Sep 21, 2022
Genetic Variants of the COL4A3 , COL4A4 , and COL4A5 Genes Contribute to Thinned Glomerular Basement Membrane Lesions in Sporadic IgA Nephropathy Patients.

Xiaohan Yuan, Qing Su, Hui Wang

Pageof 2

Frequent Collaborators

6 joint publications

Sufang Shi

5 joint publications

Xujie Zhou

4 joint publications

Li Zhu

3 joint publications

Hong Zhang